EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validation of a Quantitative Urinary GHB Enzymatic Assay on Siemens Atellica® : Assessment and Correction of Ethanol Interference

J-J Bendjilali-Sabiani, S. Nabil, Y. Cazaubon, J. Descoeur, O. Mathieu, C. Eiden

Practical Laboratory Medicine · 2026-11 · e00565

DOI: 10.1016/j.plabm.2026.e00565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Laboratory Medicine, 2026-11. Verfasst von J-J Bendjilali-Sabiani und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital of Montpellier.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid gamma-hydroxybutyrate (GHB) testing may be clinically useful when prompt results are needed to support patient management. This study aimed to validate a quantitative enzymatic assay for urinary GHB on the Siemens Atellica® clinical chemistry analyser, assess its agreement with GC-MS/MS, and quantify the effect of urinary ethanol interference. Analytical validation included linearity, sensitivity, precision, carryover, stability and dilution integrity. The assay was linear over 5-100 mg/L, with a limit of detection of 0.86 mg/L and a lower limit of quantification of 3 mg/L. Repeatability and intermediate precision fulfilled predefined acceptance criteria. Relative Bland-Atlman analysis of 34 quantifiable paired samples showed a mean relative difference of +10.1% compared with GC-MS/MS. The enzymatic assay yielded 100% sensitivity and 82.4% specificity for exogenous GHB exposure at a 10 mg/L threshold, whereas a 14 mg/L threshold achieved 97% sensitivity and 100% specificity. Urinary ethanol produced an additive positive interference. A correction factor of 2 mg/L of apparent GHB per g/L of ethanol was derived and independently verified. In ethanol-supplemented samples, application of this correction reduced the mean relative difference versus GC-MS/MS from +58.0% to +9.5%. The enzymatic assay provides a rapid quantitative method for urinary GHB measurement on Atellica®, showing good agreement with GC-MS/MS method. Quantification of urinary ethanol interference enabled correction of the apparent GHB concentration. Nevertheless, results near the decision threshold should be interpreted cautiously and confirmed by GC-MS/MS when appropriate.

Förderung

  • University Hospital of Montpellier

Zitieren

APA

Bendjilali-Sabiani, J., Nabil, S., Cazaubon, Y., Descoeur, J., Mathieu, O., & Eiden, C. (2026). Validation of a Quantitative Urinary GHB Enzymatic Assay on Siemens Atellica® : Assessment and Correction of Ethanol Interference. Practical Laboratory Medicine, e00565. https://doi.org/10.1016/j.plabm.2026.e00565

Vancouver

Bendjilali-Sabiani J, Nabil S, Cazaubon Y, Descoeur J, Mathieu O, Eiden C. Validation of a Quantitative Urinary GHB Enzymatic Assay on Siemens Atellica® : Assessment and Correction of Ethanol Interference. Practical Laboratory Medicine. 2026:e00565. doi:10.1016/j.plabm.2026.e00565

BibTeX
@article{BendjilaliSabiani2026,
  author = {Bendjilali-Sabiani, J-J and Nabil, S. and Cazaubon, Y. and Descoeur, J. and Mathieu, O. and Eiden, C.},
  title = {Validation of a Quantitative Urinary GHB Enzymatic Assay on Siemens Atellica® : Assessment and Correction of Ethanol Interference},
  journal = {Practical Laboratory Medicine},
  year = {2026},
  pages = {e00565},
  doi = {10.1016/j.plabm.2026.e00565}
}
Kostenlos starten →